Chengyuan Gu

723 total citations
50 papers, 443 citations indexed

About

Chengyuan Gu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Chengyuan Gu has authored 50 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 21 papers in Pulmonary and Respiratory Medicine and 15 papers in Surgery. Recurrent topics in Chengyuan Gu's work include Bladder and Urothelial Cancer Treatments (11 papers), Prostate Cancer Treatment and Research (10 papers) and Renal cell carcinoma treatment (7 papers). Chengyuan Gu is often cited by papers focused on Bladder and Urothelial Cancer Treatments (11 papers), Prostate Cancer Treatment and Research (10 papers) and Renal cell carcinoma treatment (7 papers). Chengyuan Gu collaborates with scholars based in China, United States and South Korea. Chengyuan Gu's co-authors include Yao Zhu, Dingwei Ye, Dingwei Ye, Bo Dai, Hailiang Zhang, Jianfeng Xu, Yuanyuan Qu, Hailiang Zhang, Fangning Wan and Guiming Zhang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Oncogene.

In The Last Decade

Chengyuan Gu

47 papers receiving 439 citations

Peers

Countries citing papers authored by Chengyuan Gu

Since Specialization

Citations

This map shows the geographic impact of Chengyuan Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengyuan Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengyuan Gu more than expected).

Fields of papers citing papers by Chengyuan Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengyuan Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengyuan Gu. The network helps show where Chengyuan Gu may publish in the future.

Co-authorship network of co-authors of Chengyuan Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Chengyuan Gu. A scholar is included among the top collaborators of Chengyuan Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengyuan Gu. Chengyuan Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Expansion of peripheral helper T cells in the peripheral blood of patients with chronic graft-versus-host disease 2025 ·Annals of Hematology ·Yuanyuan Du, (unknown), (unknown), (unknown), Mimi Xu, Li Wan, Meng Zhou, (unknown), Chengyuan Gu, Ruju Wang, Yue Han, Yongxia Wu, Depei Wu, Yuejun Liu	0
2	Longitudinal MRI‐Driven Multi‐Modality Approach for Predicting Pathological Complete Response and B Cell Infiltration in Breast Cancer 2025 ·Advanced Science ·Yu‐Hong Huang, Zhong‐Song Shi, Teng Zhu, (unknown), Yi Li, Wei Li, Han Qiu, Siqi Wang, (unknown), Zhi‐Yong Wu, Ying Lin, Qian Wang, Wenchao Gu, Chengyuan Gu, Xing Song, Yang Zhou, Daogang Guan, Kun Wang	10
3	Real‐world evidence of avatrombopag for the treatment of immune thrombocytopenia intolerant or ineffective to eltrombopag/hetrombopag 2024 ·British Journal of Haematology ·(unknown), (unknown), (unknown), Yun Li, Chengyuan Gu, (unknown), (unknown), (unknown), Jie Yin	1
4	Impaired megakaryopoiesis due to aberrant macrophage polarization via BTK/Rap1/NF-κB pathway in sepsis-induced thrombocytopenia 2024 ·Molecular Therapy ·Ziyan Zhang, Meng Zhou, Yaqiong Tang, Jiaqian Qi, Xiaoyan Xu, Peng Wang, (unknown), Tingting Pan, (unknown), Shuhui Jiang, Xue–Qian Li, Chengyuan Gu, Zhenzhen Yao, (unknown), (unknown), (unknown), Depei Wu, Yue Han	3
5	A Novel Role of Acellular Hemoglobin in Hemolytic Thrombosis 2023 ·SSRN Electronic Journal ·Yan Wan, Yaxuan Wei, (unknown), Yuanyuan Liu, Linru Xu, Chengyuan Gu, Zhifeng Yu, (unknown), Qing Zhang, Wei Deng	1
6	A novel role of acellular hemoglobin in hemolytic thrombosis 2023 ·Thrombosis Research ·Yan Wan, Yaxuan Wei, (unknown), Yuanyuan Liu, Linru Xu, Chengyuan Gu, Zhifeng Yu, (unknown), Qing Zhang, Wei Deng	1
7	Prognostic value of dynamic cardiac biomarkers in patients with acquired refractory thrombocytopenic purpura: A retrospective study in Chinese population 2022 ·Journal of Clinical Laboratory Analysis ·(unknown), Chengyuan Gu, Ruju Wang, Jiaqian Qi, Jun Wang, Tingbo Jiang, (unknown), Depei Wu, Tao You, Jianhong Fu	2
8	The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma 2022 ·Molecular Medicine ·Chengyuan Gu, Bo Dai, Yao Zhu, (unknown), Hongkai Wang, (unknown), Xiaojian Qin	5
9	The expression and prognostic value of transporter 1, ATP binding cassette subfamily B member in clear cell renal cell cancer with experimental validation 2022 ·Frontiers in Oncology ·(unknown), Xi Tian, Yue Wang, Junjie Wang, Shiqi Ye, Yongqiang Huang, Yuanyuan Qu, Kun Chang, Guohai Shi, Dingwei Ye, Chengyuan Gu	2
10	Identification of low-frequency variants of UGT1A3 associated with bladder cancer risk by next-generation sequencing 2021 ·Oncogene ·Rui Zheng, Mulong Du, Yuqiu Ge, Fang Gao, Junyi Xin, Qiang Lv, Chao Qin, Yao Zhu, Chengyuan Gu, (unknown), (unknown), Zheng Guo, Shuai Ben, Haiyan Chu, Dingwei Ye, Zhengdong Zhang, Meilin Wang	10
11	Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation 2021 ·Frontiers in Oncology ·Chengyuan Gu, Junjie Wang, Hailiang Zhang, Guohai Shi, Dingwei Ye	5
12	Prostate Cancer Screening Using Prostate-Specific Antigen Tests in a High-Risk Population in China: A Cost-Utility Analysis 2021 ·Current Therapeutic Research ·Xiaojian Qin, Dingwei Ye, Chengyuan Gu, Yongqiang Huang, Weijie Gu, Bo Dai, Hailiang Zhang, Yao Zhu, Yang Han, Shuli Qu	1
13	The Rare Variant rs35356162 in UHRF1BP1 Increases Bladder Cancer Risk in Han Chinese Population 2020 ·Frontiers in Oncology ·Junlong Wu, Meilin Wang, Haitao Chen, Jianfeng Xu, Guiming Zhang, Chengyuan Gu, Qiang Ding, Qingyi Wei, Yao Zhu, Dingwei Ye	7
14	Diagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese population 2016 ·Scientific Reports ·Yuanyuan Qu, Chengyuan Gu, Hongkai Wang, Kun Chang, Xiaoqun Yang, Xiaoyan Zhou, Bo Dai, Yao Zhu, Guohai Shi, Hailiang Zhang, Dingwei Ye	27
15	Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence 2015 ·Prostate Cancer and Prostatic Diseases ·Chengyuan Gu, (unknown), Yongxue Zhu, Yuan Qu, (unknown), (unknown), Yajun Yang, J. Wang, Jin Li, Qingyi Wei, Dingwei Ye	8
16	Genetic variants in insulin-like growth factor binding protein-3 are associated with prostate cancer susceptibility in Eastern Chinese Han men 2015 ·OncoTargets and Therapy ·Guiming Zhang, Yao Zhu, Fang Liu, Chengyuan Gu, Haitao Chen, Jianfeng Xu, Dingwei Ye	9
17	Surgical treatment of primary disease for penile squamous cell carcinoma: A Surveillance, Epidemiology, and End Results database analysis 2015 ·Oncology Letters ·Yao Zhu, Weijie Gu, (unknown), Chengyuan Gu, Dingwei Ye	11
18	Serum lipid profiles: novel biomarkers predicting advanced prostate cancer in patients receiving radical prostatectomy 2014 ·Asian Journal of Andrology ·Dingwei Ye, Gui-Ming Zhang, Xiaojian Qin, Hailiang Zhang, Wen-jun Xiao, Yao Zhu, Chengyuan Gu, Bo Dai, Guo-Hai Shi	12
19	Lower skeletal muscle index and early complications in patients undergoing radical cystectomy for bladder cancer 2014 ·World Journal of Surgical Oncology ·Fangning Wan, Yao Zhu, Chengyuan Gu, Xudong Yao, Yijun Shen, Bo Dai, Shilin Zhang, Hailiang Zhang, Jingyi Cheng, Dingwei Ye	46
20	Polymorphisms in the mTOR Gene and Risk of Sporadic Prostate Cancer in an Eastern Chinese Population 2013 ·PLoS ONE ·Qiao‐Xin Li, Chengyuan Gu, Yao Zhu, Mengyun Wang, Yajun Yang, Jiucun Wang, Jin Li, Mei-Ling Zhu, (unknown), Jing He, Xiaoyan Zhou, (unknown), Qingyi Wei	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact